Double-blinded MOBILE2-trial found that mechanical bowel preparation and oral antibiotics reduced the rate of overall morbidity, surgical site infections and anastomotic leaks compared to mechanical bowel preparation only prior anterior rectal resection. https://t.co/1mVNqwWmMx
Recuerda inscribirte en el webinar sobre Cáncer de recto, una nueva actividad de la AECP para que estés siempre al día.
Con la colaboración de la Asociación Colombiana de Coloproctología y excelentes ponentes @R_Perez_MD
Inscríbete de forma gratuita 👉 https://t.co/2q7WtrxMTM
#ICYMI Complications after open and laparoscopic right-sided colectomy with central lymphadenectomy for colon cancer: randomized controlled trial
➡️https://t.co/mcQFrchOJx
This study found no significant difference in complications between the two groups. Standardized oncologic right-sided colectomy with central lymphadenectomy along the mesenterial root was performed safely, both open and laparoscopic, with incidence of major complications ranging between 4.6 and 7.9 per cent and no re-operations for anastomotic leakage. Radicality in terms of lymphadenectomy was comparable between the two groups.
Great wory by Kristin B Lygre, Geir E Eide, Havard M Forsmo, Aly Dicko, Kristian E Storli, Frank Pfeffer!
#colorectalcancer @FightCRC #StepUp4CRC #SoMe4Surgery @me4_so #MedTwitter #SurgEd #Surgery @for_surgery@for_surgeons@modern_surgeon@ACPGBI_EduTrain@dice_europe@BJSAcademy@BJSurgery@young_bjs@juliomayol@JJEarnshaw
@OUPMedicine @escp_tweets@Haraldsplass
Join @JuanGarcaArmen1 for a deep exploration of Sphincter Repair and faecal incontinence insights!
Don't miss it on 07 December at 17:00 CET.
Register today: https://t.co/LOGZHCHO6k
Starting chemotherapy over eight weeks after surgery is detrimental. This study suggests there is no harm (and may be benefit) in starting it two weeks after surgery.
Read the paper in full 👇👇
https://t.co/X62nrdAv0A
@BjsOpen@JJEarnshaw
Hoy es un día grande pra la Fundación. Dos equipos de voluntarios salen a hacer sus campañas. 18 voluntarios van a Yerevan, Armenia. Una campaña con la organización más difícil de la historia de CA, en un momento complicado, pero con mucha ilusión por ayudar a esa comunidad.
Prelim results of our 🇺🇸 🇨🇦 MCT phase 2 trial of taTME! Good onc results, 2% conversion for tumors mostly w/i 6cm of distal rectum, in cohort with 70% men and 33% with BMI>30 ! Special thx to all our PIs, @ASCRS_1 @SAGES_Updates and sponsors https://t.co/i12tf8utX1